Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants

Affiliations

• ¹ Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.
• ² Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
• ³ Department of Medicine, University of Montreal, CRCHUM, Montreal, Canada.
• ⁴ Zhongshan Hospital, Fudan University, Shanghai, China.
• ⁵ Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
• ⁶ Department of Cardiology, Peking University First Hospital, Beijing, China.
• ⁷ Bayer Pharmaceuticals China, Beijing, China.
• ⁸ Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
• ⁹ Cardiology Unit, Karolinska University Hospital Solna, Stockholm, Sweden.
• ¹⁰ Bayer AG, Pharma Division, Berlin, Germany.
• ¹¹ Department of Cardiology and Structural Heart Diseases, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
• ¹² Department of Neurosciences and Preventive Medicine, Danube-University Krems, Krems, Austria; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland; King Abdulaziz University, Jeddah, Saudi Arabia; Dasman Diabetes Institute, Dasman, Kuwait.
• ¹³ China-Japan Friendship Hospital, Beijing, China.
• ¹⁴ People's Hospital of Peking University, Beijing, China.
• ¹⁵ Department of Endocrinology, People's Liberation Army General Hospital, Beijing, China.
• ¹⁶ Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom. Electronic address: [email protected].